---
figid: PMC4571892__zbc0401524110006
figlink: /pmc/articles/PMC4571892/figure/F6/
number: F6
caption: Impact of HER2-mediated inhibition of MLK3 kinase activity on breast cancer
  cell death and tumorigenesis (survival). Inhibition of HER2-HER3 pathway by trastuzumab
  or lapatinib inactivates downstream PI3K/AKT. The inhibition of AKT leads to activation
  of MLK3 and its downstream MKK4/7-JNK axis and promotes HER2+ breast cancer cell
  death via induction of pro-apoptotic factors by AP1 transcription factor. On contrary,
  the activation of HER3 by its ligand, heregulin (HRG), or amplification of HER2
  activates the PI3K/AKT pathway and inhibition of MLK3 kinase activity via S674 phosphorylation
  by AKT. The inhibition of MLK3 ultimately prevents the downstream JNK-mediated AP1
  activation and induction of pro-apoptotic factors, finally leading to tumorigenesis.
pmcid: PMC4571892
papertitle: Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity
  to Support Breast Cancer Cell Survival.
reftext: Subhasis Das, et al. J Biol Chem. 2015 Aug 28;290(35):21705-21712.
pmc_ranked_result_index: '64720'
pathway_score: 0.9397199
filename: zbc0401524110006.jpg
figtitle: Impact of HER2-mediated inhibition of MLK3 kinase activity on breast cancer
  cell death and tumorigenesis (survival)
year: '2015'
organisms: Homo sapiens
ndex: 111e2ef6-df06-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4571892__zbc0401524110006.html
  '@type': Dataset
  description: Impact of HER2-mediated inhibition of MLK3 kinase activity on breast
    cancer cell death and tumorigenesis (survival). Inhibition of HER2-HER3 pathway
    by trastuzumab or lapatinib inactivates downstream PI3K/AKT. The inhibition of
    AKT leads to activation of MLK3 and its downstream MKK4/7-JNK axis and promotes
    HER2+ breast cancer cell death via induction of pro-apoptotic factors by AP1 transcription
    factor. On contrary, the activation of HER3 by its ligand, heregulin (HRG), or
    amplification of HER2 activates the PI3K/AKT pathway and inhibition of MLK3 kinase
    activity via S674 phosphorylation by AKT. The inhibition of MLK3 ultimately prevents
    the downstream JNK-mediated AP1 activation and induction of pro-apoptotic factors,
    finally leading to tumorigenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K7
  - MAPK10
  - FOSL1
  - AKT2
  - FOSB
  - MAP2K4
  - MAP3K11
  - AKT1
  - PIK3R5
  - FOSL2
  - JUN
  - FOS
  - AKT3
  - MAPK9
  - PIK3CB
  - JUNB
  - PIK3CG
  - MAPK8
  - JUND
  - PIK3CD
  - PIK3R6
  - PIK3R4
  - PIK3CA
  - PIK3R3
  - HRG
  - Cancer
genes:
- word: MKK4/7
  symbol: MKK7
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: MKK4/7
  symbol: MKK4
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MLK3
  symbol: MLK3
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K11
  entrez: '4296'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: HRG
  symbol: HRG
  source: hgnc_symbol
  hgnc_symbol: HRG
  entrez: '3273'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4571892__F6
redirect_from: /figures/PMC4571892__F6
figtype: Figure
---
